{
  "metadata": {
    "title": "Effects of Intensive Glucose Lowering in Type 2 Diabetes",
    "authors": "The Action to Control Cardiovascular Risk in Diabetes Study Group",
    "journal": "New England Journal of Medicine",
    "year": 2008,
    "doi": "10.1056/NEJMoa0802743",
    "pmid": null,
    "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa0802743"
  },
  "trial_characteristics": {
    "sample_size": 10251,
    "intervention_description": "Intensive glucose-lowering therapy targeting a glycated hemoglobin level below 6.0%",
    "control_description": "Standard therapy targeting a glycated hemoglobin level of 7.0 to 7.9%",
    "primary_outcome": "Composite outcome of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes",
    "inclusion_criteria": [
      "Type 2 diabetes",
      "Participants aged 40 to 79 years with cardiovascular disease or 55 to 79 years with anatomical evidence of subclinical cardiovascular disease, albuminuria, left ventricular hypertrophy, or at least two additional risk factors for cardiovascular disease"
    ],
    "exclusion_criteria": null,
    "baseline_characteristics": "Participants had an average age of 62 years, and 38% were female; most participants had longstanding diabetes with an average duration of 10 years.",
    "randomization_method": "Participants were randomly assigned to treatment groups using a permuted block method stratified according to clinical center."
  },
  "results": {
    "primary_outcome_result": "The intensive therapy group did not have a significant reduction in major cardiovascular events compared to the standard therapy group. The intervention was associated with a higher risk of death during the follow-up period (hazard ratio for death, 1.22; 95% CI, 1.01 to 1.46; P=0.04).",
    "subgroup_analyses_reported": true,
    "subgroups_analyzed": [
      "Age",
      "Duration of diabetes",
      "Baseline glycated hemoglobin levels"
    ],
    "heterogeneity_findings": "The hazard ratio for cardiovascular events and death did not significantly differ across predefined subgroups.",
    "adverse_events": "Higher incidence of severe hypoglycemia observed in the intensive therapy group compared to the standard group."
  },
  "study_limitations": [
    "Possibility of differential adherence to treatment protocols",
    "Potential for biases in reporting events due to open-label design",
    "High dropout rate among participants"
  ],
  "relevant_to_hypotheses": "The results indicate potential trade-offs in intensive diabetes management, with findings relevant for hypotheses around treatment heterogeneity in cardiovascular outcomes in different demographic or clinical subgroups.",
  "confidence": "high"
}